Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Langer

Showing results (181-190 of 218) with videos related to

Pageof 22
Sort By:
Annals of Surgical Oncology|May 24, 2015
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric AdenocarcinomaChristoph Springfeld, Christiane Wiecha, Romy Kunzmann, et al.
Annals of Surgery|November 8, 2014
The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological studyFlorian Liebl, Ihsan Ekin Demir, Katharina Mayer, et al.
Environmental Science & Technology|June 18, 2024
Airborne Aluminum as an Underestimated Source of Human Exposure: Quantification of Aluminum in 24 Human Tissue Types Reveals High Aluminum Concentrations in Lung and Hilar Lymph Node TissuesClara Ganhör, Lukas Mayr, Julia Zolles, et al.
BMC Cancer|December 14, 2011
Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Birgit Luber, Joëlle Deplazes, Gisela Keller, et al.
Plos One|November 24, 2011
Histological assessment of PAXgene tissue fixation and stabilization reagentsMarcel Kap, Frank Smedts, Wolter Oosterhuis, et al.
Human Pathology|May 16, 2021
Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer ReportingAlfred K Lam, Michael J Bourke, Renyin Chen, et al.
Oncotarget|October 27, 2015
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancerChristian Schafroth, José A Galván, Irene Centeno, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 20, 2022
Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learningOliver Lester Saldanha, Hannah Sophie Muti, Heike I Grabsch, et al.
The Lancet. Oncology|August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trialDerek Alderson, David Cunningham, Matthew Nankivell, et al.
Oncotarget|July 13, 2014
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patientsMelina Helbling, Anne Lukesch, Aladin Haimovici, et al.
Pageof 22

Showing results (181-190 of 218) with videos related to

Sort By:
Pageof 22
Annals of Surgical Oncology|May 24, 2015
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric AdenocarcinomaChristoph Springfeld, Christiane Wiecha, Romy Kunzmann, et al.
Annals of Surgery|November 8, 2014
The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological studyFlorian Liebl, Ihsan Ekin Demir, Katharina Mayer, et al.
Environmental Science & Technology|June 18, 2024
Airborne Aluminum as an Underestimated Source of Human Exposure: Quantification of Aluminum in 24 Human Tissue Types Reveals High Aluminum Concentrations in Lung and Hilar Lymph Node TissuesClara Ganhör, Lukas Mayr, Julia Zolles, et al.
BMC Cancer|December 14, 2011
Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Birgit Luber, Joëlle Deplazes, Gisela Keller, et al.
Plos One|November 24, 2011
Histological assessment of PAXgene tissue fixation and stabilization reagentsMarcel Kap, Frank Smedts, Wolter Oosterhuis, et al.
Human Pathology|May 16, 2021
Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer ReportingAlfred K Lam, Michael J Bourke, Renyin Chen, et al.
Oncotarget|October 27, 2015
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancerChristian Schafroth, José A Galván, Irene Centeno, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 20, 2022
Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learningOliver Lester Saldanha, Hannah Sophie Muti, Heike I Grabsch, et al.
The Lancet. Oncology|August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trialDerek Alderson, David Cunningham, Matthew Nankivell, et al.
Oncotarget|July 13, 2014
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patientsMelina Helbling, Anne Lukesch, Aladin Haimovici, et al.
Pageof 22